The conflicting safety signal One real-world evidence study found that patients receiving GLP-1 receptor agonists had higher risks of certain autoimmune conditions, including ulcerative colitis, rheumatoid arthritis, autoimmune thyroiditis, ankylosing spondylitis, and psoriasis, compared to those on DPP-4 inhibitors
[DOI] [PubMed] [Google Scholar] [52].Prausnitz MR, Microneedles for transdermal drug delivery, Adv Drug Deliv Rev 56(5) (2004) 5817
(It could be approved by late 2026.) Still, some guys like Johic are buying retatrutide at their own risk through a gray market of medical clinics and med spas, research peptide outlets (where drugs are sold for research purposes), compounding pharmacies, and e-commerce sites
Choosing between Henry Meds and Remedy Meds depends on your specific healthcare needs
Who Can Benefit Most from GLP-1s
This format maximizes stability during shipping and storage